121 related articles for article (PubMed ID: 28433985)
21. Reticulate pigmentation due to 5-fluorouracil.
Allen BJ; Parker D; Wright AL
Int J Dermatol; 1995 Mar; 34(3):219-20. PubMed ID: 7538496
[No Abstract] [Full Text] [Related]
22. A case of late-onset severe cardiotoxicity from 5-fluorouracil therapy resulting in death.
Wijesinghe N
N Z Med J; 2007 Nov; 120(1266):U2836. PubMed ID: 18264205
[TBL] [Abstract][Full Text] [Related]
23. Hand and foot syndrome secondary to capecitabine.
Lal HS
Indian J Dermatol Venereol Leprol; 2014; 80(5):427-30. PubMed ID: 25201844
[TBL] [Abstract][Full Text] [Related]
24. 5-FU-induced peripheral neuropathy: a rare complication of a well-known drug.
van Laarhoven HW; Verstappen CC; Beex LV; Kappelle AC; Punt CJ
Anticancer Res; 2003; 23(1B):647-8. PubMed ID: 12680161
[TBL] [Abstract][Full Text] [Related]
25. [Patient preference for oral chemotherapy].
Schöffski P
Krankenpfl J; 2002; 40(1-2):40-1. PubMed ID: 12035416
[No Abstract] [Full Text] [Related]
26. [pericarditis following 5-fluorouracil administration].
Maréchal S; Racaru V; Houbiers G; Graas MP
Rev Med Liege; 2015; 70(7-8):360-6. PubMed ID: 26376561
[TBL] [Abstract][Full Text] [Related]
27. Cutaneous Drug REactions: Annular, polycyclic erythematous exanthema in an oncology patient.
Hernandez-Aragues I; Baniandrés-Rodríguez O; Avilés-Izquierdo JA; Vilas-Boas PT
Eur J Dermatol; 2017 Jun; 27(3):337-338. PubMed ID: 28677584
[No Abstract] [Full Text] [Related]
28. Pneumatosis intestinalis due to 5-fluorouracil chemotherapy.
Vargas A; Pagés M; Buxó E
Gastroenterol Hepatol; 2016 Dec; 39(10):672-673. PubMed ID: 26547612
[No Abstract] [Full Text] [Related]
29. [A combination of radiotherapy and chemotherapy with platidiam and fluorouracil in patients with head and neck cancer].
Shparyk IaV; Kravets AI; Bilyns'kyĭ BT; Kuftiak OF
Lik Sprava; 1996; (3-4):153-7. PubMed ID: 9035857
[No Abstract] [Full Text] [Related]
30. Onycholysis with the appearance of a "sunset" secondary to capecitabine.
Maino KL; Norwood C; Stashower ME
Cutis; 2003 Sep; 72(3):234-6. PubMed ID: 14533836
[TBL] [Abstract][Full Text] [Related]
31. [Capsule instead of infusion--new oral chemotherapy option].
Köhne CH
Krankenpfl J; 2002; 40(1-2):42-3. PubMed ID: 12035417
[No Abstract] [Full Text] [Related]
32. Capecitabine-induced acral and mucosal hyperpigmentation.
Verma P
Indian J Dermatol Venereol Leprol; 2017; 83(5):583. PubMed ID: 28656912
[No Abstract] [Full Text] [Related]
33. Leukoencephalopathy following chemotherapy for colonic carcinoma.
Mak W; Cheng PW; Cheung RT
Clin Radiol; 2001 Apr; 56(4):333-5. PubMed ID: 11286589
[No Abstract] [Full Text] [Related]
34. [Systemic palliative chemotherapy with 5-fluorouracil and leucovorin in disseminated colorectal cancer].
Wiboltt K; Raskov HH
Ugeskr Laeger; 1999 Jun; 161(25):3827-32. PubMed ID: 10412300
[TBL] [Abstract][Full Text] [Related]
35. Fluorouracil induces myocardial ischemia with increases of plasma brain natriuretic peptide and lactic acid but without dysfunction of left ventricle.
Jensen SA; Hasbak P; Mortensen J; Sørensen JB
J Clin Oncol; 2010 Dec; 28(36):5280-6. PubMed ID: 21079148
[TBL] [Abstract][Full Text] [Related]
36. [Reversible cardiogenic shock under 5-fluorouracil treatment].
Bakouboula B; Morel O; Douchet MP; Chauvin M
Ann Cardiol Angeiol (Paris); 2005 Aug; 54(4):216-9. PubMed ID: 16104623
[TBL] [Abstract][Full Text] [Related]
37. Irinotecan/5-fluorouracil/leucovorin in advanced colorectal cancer: Oncologic Drugs Advisory committee summary.
Oncologic Drugs Advisory Committee
Clin Colorectal Cancer; 2002 May; 2(1):8-10. PubMed ID: 12453328
[No Abstract] [Full Text] [Related]
38. Postmarketing re-evaluation of irinotecan plus 5-fluorouracil/leucovorin for first-line treatment of metastatic colorectal cancer.
Chico IM; Pazdur R
Clin Colorectal Cancer; 2002 May; 2(1):11-2. PubMed ID: 12453329
[No Abstract] [Full Text] [Related]
39. [Dose-intensive chemotherapy with continuous infusion 5-fluorouracil].
Tichler T; Ghodsizade E; Katz A; Rath P; Berger R; Brenner H
Harefuah; 1999 Nov; 137(9):387-90, 430. PubMed ID: 11419042
[TBL] [Abstract][Full Text] [Related]
40. Nursing considerations for capecitabine-based combination therapy.
Becze E
ONS Connect; 2009 Apr; 24(4):14-5. PubMed ID: 19413236
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
